Merck & Co., Inc. (MRK) vs Quhuo Limited (QH)
See how Merck & Co., Inc. and Quhuo Limited differ across market data and performance, so you can decide which asset best fits your strategy.
$152.2
NYSE
Merck & Co., Inc. develops pharmaceutical products across multiple therapeutic areas, including cardiometabolic disorders, oncology, and infectious diseases. In cancer treatment, its immuno-oncology portfolio, led by Keytruda, represents a significant driver of total revenue. The company also maintains a strong vaccines business focused on preventing pediatric illnesses, alongside Gardasil for human papillomavirus. In addition, Merck markets animal health products. Geographically, 47% of the company’s sales come from its U.S. human health segment, which includes pharmaceuticals and vaccines.
View Full Page$4.31
NasdaqCM
Key Metrics Comparison
Merck & Co., Inc.MRK
Market Cap$375.504B
Price$152.2
24h Change+12.60%
24h Volume$32.55M
Employees73,000
Shares Outstanding2,469,879,206
Quhuo LimitedQH
Market Cap$378.963B
Price$4.31
24h Change-2.16%
24h Volume$162.1K
Employees474
Shares OutstandingN/A
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
MRK
49.8%QH
50.2%Volume Share
Share of combined 24h volume
MRK
99.5%QH
1.0%24h Performance
Price change over last 24 hours
MRK
12.60%QH
-2.16%Price Comparison
Merck & Co., Inc.
Quhuo Limited